Skip to main content

Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial

User login

Username

Password

Reset your password

Type	Lead	score